'Young blood' treatments to stop aging, disease are a 'significant public health concern,' FDA says.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA discourages people against 'young blood' infusions, which make unproven claims to reverse agingThe FDA is advising against 'young blood' infusions, in which people are infused with plasma from young donors. It warns consumers that clinics are making unproven claims that the treatment can reverse aging.
Lire la suite »
FDA warns against using young blood as medical treatmentThe US Food and Drug Administration warned against using plasma infusions from young blood donors to ward off the effects of normal aging as well as other more serious conditions.
Lire la suite »
'Young blood' company Ambrosia halts patient treatments after FDA warningThe FDA warned consumers against infusions of plasma from young donors, saying there is no evidence that they slow aging or memory loss, and can be dangerous.
Lire la suite »
Ketamine-like depression treatment on track for FDA approvalA ketamine-like drug for treatment-resistant depression was backed by a US Food and Drug Administration advisory committee on Tuesday. If it is then approved by the FDA, the drug -- called esketamine -- may provide a new option for patients with major depressive disorder who have tried at least two other antidepressants without success.
Lire la suite »